174 related articles for article (PubMed ID: 10793012)
1. Regional citrate anticoagulation in continuous venovenous hemodiafiltration.
Kutsogiannis DJ; Mayers I; Chin WD; Gibney RT
Am J Kidney Dis; 2000 May; 35(5):802-11. PubMed ID: 10793012
[TBL] [Abstract][Full Text] [Related]
2. Regional citrate anticoagulation for high volume continuous venovenous hemodialysis in surgical patients with high bleeding risk.
Kalb R; Kram R; Morgera S; Slowinski T; Kindgen-Milles D
Ther Apher Dial; 2013 Apr; 17(2):202-12. PubMed ID: 23551677
[TBL] [Abstract][Full Text] [Related]
3. Regional citrate anticoagulation for continuous venovenous hemodiafiltration using calcium-containing dialysate.
Gupta M; Wadhwa NK; Bukovsky R
Am J Kidney Dis; 2004 Jan; 43(1):67-73. PubMed ID: 14712429
[TBL] [Abstract][Full Text] [Related]
4. Citrate clearance in children receiving continuous venovenous renal replacement therapy.
Chadha V; Garg U; Warady BA; Alon US
Pediatr Nephrol; 2002 Oct; 17(10):819-24. PubMed ID: 12376810
[TBL] [Abstract][Full Text] [Related]
5. Safety of regional citrate anticoagulation for continuous sustained low efficiency dialysis (C-SLED) in critically ill patients.
Finkel KW; Foringer JR
Ren Fail; 2005; 27(5):541-5. PubMed ID: 16152991
[TBL] [Abstract][Full Text] [Related]
6. Improving the delivery of continuous renal replacement therapy using regional citrate anticoagulation.
Swartz R; Pasko D; O'Toole J; Starmann B
Clin Nephrol; 2004 Feb; 61(2):134-43. PubMed ID: 14989634
[TBL] [Abstract][Full Text] [Related]
7. Regional citrate anticoagulation for PrismaFlex continuous renal replacement therapy.
Burry LD; Tung DD; Hallett D; Bailie T; Carvalhana V; Lee D; Ramganesh S; Richardson R; Mehta S; Lapinsky SE
Ann Pharmacother; 2009 Sep; 43(9):1419-25. PubMed ID: 19690224
[TBL] [Abstract][Full Text] [Related]
8. Regional citrate anticoagulation in continuous venovenous haemodiafiltration using commercial solutions.
Cointault O; Kamar N; Bories P; Lavayssiere L; Angles O; Rostaing L; Genestal M; Durand D
Nephrol Dial Transplant; 2004 Jan; 19(1):171-8. PubMed ID: 14671053
[TBL] [Abstract][Full Text] [Related]
9. Renal replacement therapy with regional citrate anticoagulation as an effective method to treat hypercalcemic crisis.
Gradwohl-Matis I; Franzen M; Seelmaier C; Brunauer A; Dankl D; Dünser MW; Salmhofer H
ASAIO J; 2015; 61(2):219-23. PubMed ID: 25485561
[TBL] [Abstract][Full Text] [Related]
10. Regional citrate anticoagulation in continuous venovenous hemofiltration in critically ill patients with a high risk of bleeding.
Palsson R; Niles JL
Kidney Int; 1999 May; 55(5):1991-7. PubMed ID: 10231464
[TBL] [Abstract][Full Text] [Related]
11. Regional Citrate Anticoagulation for Continuous Kidney Replacement Therapy With Calcium-Containing Solutions: A Cohort Study.
Rhee H; Berenger B; Mehta RL; Macedo E
Am J Kidney Dis; 2021 Oct; 78(4):550-559.e1. PubMed ID: 33798636
[TBL] [Abstract][Full Text] [Related]
12. Regional citrate anticoagulation "non-shock" protocol with pre-calculated flow settings for patients with at least 6 L/hour liver citrate clearance.
Yessayan L; Sohaney R; Puri V; Wagner B; Riddle A; Dickinson S; Napolitano L; Heung M; Humes D; Szamosfalvi B
BMC Nephrol; 2021 Jul; 22(1):244. PubMed ID: 34215201
[TBL] [Abstract][Full Text] [Related]
13. The use of regional citrate anticoagulation for continuous venovenous hemodiafiltration in acute kidney injury.
Durão MS; Monte JC; Batista MC; Oliveira M; Iizuka IJ; Santos BF; Pereira VG; Cendoroglo M; Santos OF
Crit Care Med; 2008 Nov; 36(11):3024-9. PubMed ID: 18824904
[TBL] [Abstract][Full Text] [Related]
14. A Randomized Controlled Trial of Regional Citrate Versus Regional Heparin Anticoagulation for Continuous Renal Replacement Therapy in Critically Ill Adults.
Gattas DJ; Rajbhandari D; Bradford C; Buhr H; Lo S; Bellomo R
Crit Care Med; 2015 Aug; 43(8):1622-9. PubMed ID: 25853591
[TBL] [Abstract][Full Text] [Related]
15. Validation of a Protocol for Continuous Hemodiafiltration with Regional Citrate Anticoagulation with Omni®.
Whiting L; Bianchi NA; Alouazen K; Joannes-Boyau O; Chiche JD; Schneider A
Blood Purif; 2022; 51(12):1039-1047. PubMed ID: 35636389
[TBL] [Abstract][Full Text] [Related]
16. Incidence and outcome of metabolic disarrangements consistent with citrate accumulation in critically ill patients undergoing continuous venovenous hemodialysis with regional citrate anticoagulation.
Khadzhynov D; Schelter C; Lieker I; Mika A; Staeck O; Neumayer HH; Peters H; Slowinski T
J Crit Care; 2014 Apr; 29(2):265-71. PubMed ID: 24360392
[TBL] [Abstract][Full Text] [Related]
17. Ionized Magnesium and Regional Citrate Anticoagulation for Continuous Renal Replacement Therapy.
Zakharchenko M; Leden P; Rulíšek J; Los F; Brodska H; Balik M
Blood Purif; 2016; 41(1-3):41-7. PubMed ID: 26960213
[TBL] [Abstract][Full Text] [Related]
18. A novel citrate anticoagulation regimen for continuous venovenous hemodiafiltration.
Dorval M; Madore F; Courteau S; Leblanc M
Intensive Care Med; 2003 Jul; 29(7):1186-9. PubMed ID: 12761615
[TBL] [Abstract][Full Text] [Related]
19. A regional citrate anticoagulation protocol for pre-dilutional CVVHDf: the 'Modified Alabama Protocol'.
Davies H; Morgan D; Leslie G
Aust Crit Care; 2008 Aug; 21(3):154-65. PubMed ID: 18635373
[TBL] [Abstract][Full Text] [Related]
20. Normal citratemia and metabolic tolerance of citrate anticoagulation for hemodiafiltration in severe septic shock burn patients.
Mariano F; Tedeschi L; Morselli M; Stella M; Triolo G
Intensive Care Med; 2010 Oct; 36(10):1735-1743. PubMed ID: 20480135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
